Drugdiscovery >> Drugs >> News
4092
Views
Orexigen seeks approval for obesity drug Contrave in EU - drugdiscovery.com
Orexigen seeks approval for obesity drug Contrave in EU - drugdiscovery.com


If approved after an eagerly-anticipated interim analysis of a cardiovascular outcomes trial called the Light study, the drug might be launched in EU in early 2015. Contrave (naltrexone/bupropion) is designed to address two important issues tied to obesity: depression and cravings.
Read More >>


Tags: Orexigen, EU, Europe, Contrave, drug, obesity, depression, cravings - October 6, 2013
Related Articles
4126
Views
New Obesity Drug: Is it effective? New Obesity Drug: Is it effective?
Belviq, a new weight loss drug launched by a Japanese firm, seems off to a rocky start. Read More >>

Tags: obesity, Belviq, Xenical

3324
Views
Two-hormone drug might help to fight diabetes and obesity Two-hormone drug might help to fight diabetes and obesity
For long, obesity and and diabetes were cured by single-hormone drugs. New, experimental two-hormone drug however seems to be able to fight these conditions. The results are very promising. Read More >>

Tags: United States, hormones, obesity, obese, hormone

4200
Views
U.S. approval delay for albiglutide U.S. approval delay for albiglutide
GlaxoSmithKline's experimental diabetes drug albiglutide did not thrill industry analysts. Read More >>

Tags: albiglutide, GlaxoSmithKline, new diabetes drug approval

3951
Views
No FDA approval for Merck’s Bridion No FDA approval for Merck’s Bridion
Merck said that the FDA refused to approve its drug Bridion (sugammadex), which is used to reverse the effects of anesthesia after surgery in more than 50 countries. Read More >>

Tags: Bridion, sugammadex, anesthesia, Merck, FDA, approval, US

3500
Views
EU Committee recommends the approval of type 2 diabetes drug EU Committee recommends the approval of type 2 diabetes drug
Janssen’s drug, Invokana (canagliflozin), an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors is to be used to impro Read More >>

Tags: Invokana, canagliflozin, Janssen, diabetes, type 2, drug

8228
Views
Takeda's schizophrenia drug lurasidone approved in Swiss Takeda's schizophrenia drug lurasidone approved in Swiss
This is the first approval in Europe for lurasidone, which is already marketed as Latuda for schizophrenia and bipolar depression in the US and Canada. Read More >>

Tags: lurasidone, latuda, drug, schizophrenia, bipoloar disorder, Swiss, approval, Europe

12095
Views
New drug for treating myeloma approved in Europe New drug for treating myeloma approved in Europe
The European Commission has granted approval for Celgene’s drug pomalidomide for the treatment of relapsed and refractory multiple myeloma, in combination with dexamethasone. The marketing name of Read More >>

Tags: Celgene, pomalidomide, multiple myeloma,Imnovid,the European Commission approval

5157
Views
FDA experts endorse new Glaxo and Theravance COPD drug FDA experts endorse new Glaxo and Theravance COPD drug
The FDA Advisory Committee has supported the approval of the new GlaxoSmithKline and Theravance COPD combo therapy Anoro Ellipta. Read More >>

Tags: FDA, approval, anoro ellipta, COPD, new drug, therapy, Glaxo, Theravance

7595
Views
Astellas’ diarrhea drug - Irribow approved in Japan Astellas’ diarrhea drug - Irribow approved in Japan
Astellas Pharma announced the approval of the additional formulation of Irribow OD Tablets for treatment of diarrhea-predominant irritable bowel syndrome in Japan. Read More >>

Tags: Irribow, Astellas, diarrhea, irritable bowel syndrome, approval

13332
Views
New  erectile dysfunction drug approved  in Ireland and the Netherlands New erectile dysfunction drug approved in Ireland and the Netherlands
Apricus Biosciences has been granted marketing authorization for Vitaros(R) indicated for the treatment of patients with erectile dysfunction. It is already approved in Sweden and the United Kingdom Read More >>

Tags: Vitaros, Apricus Biosciences, erectile dysfunction, approval, marketing authorization

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013